Genetic testing for cancer in diverse ethnic groups
Official title: GEMINI - Cancer Genetic Testing in Ethnic Populations
Run by Mayo Clinic · NCT04475640 · Data updated 2026-11-12
This study is testing how genetic testing can help cancer patients from different ethnic backgrounds understand their risks and improve their personalized care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1800 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 2 sites (Scottsdale, Arizona and 1 other locations) |
| Status | Recruiting |
| Started | January 13, 2020 |
| Main results expected | October 15, 2028 |
| Study ends | October 15, 2028 |
| Registry record updated | April 2, 2026 |
| Trial ID | NCT04475640 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults diagnosed with solid tumor cancers who self-identify as part of various ethnic populations and are seeking treatment at Mayo Clinic.
✕Probably not a fit
Patients who have undergone extensive germline genetic testing within the last 24 months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the prevalence of genetic mutations in cancer patients from various ethnic backgrounds at Mayo Clinic Arizona and Mayo Clinic Florida. It aims to integrate cancer genetic testing into standard oncology care by collecting blood or saliva samples for analysis. The study will assess the impact of genetic testing on cancer risk stratification and individualized screening, comparing results from multi-gene panel testing to traditional guidelines. By focusing on diverse populations, the trial seeks to enhance understanding of genetic risks associated with different ethnicities.
Why it matters
Potential benefit: If successful, this study could lead to improved cancer risk assessment and personalized screening strategies for patients from diverse ethnic backgrounds.
How similar studies have gone: Other studies have shown success in integrating genetic testing into cancer care, particularly in diverse populations, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients at least 18 years of age * Individuals diagnosed with any solid tumor cancer including, but not limited to, gastrointestinal, breast, gynecological, genitourinary, skin, central nervous system (CNS)/brain, head/neck, musculoskeletal or cancer of unknown primary; and presenting to Mayo Clinic (MC Arizona or MC Florida) for clinical management/treatment; and patients receive genetic testing as described above * Self-identified as being from various ethnic populations including Hispanic/Latino, Native American/Alaskan, African American (including of African descent), Asian and other European populations * Blood collection is feasible (health, access and/or tolerability) for requested blood sample(s) * Individuals have agreed to participate and signed the study informed consent form Exclusion Criteria: * Patients who have had prior germline genetic testing involving a 40+ gene panel within the last 24 months at Mayo Clinic and available for review by the research coordinator at time of consent * Past or current history of hematological cancer (including leukemias, multiple myeloma) * All bone marrow transplants
Where it's running
-
Mayo Clinic in Arizona
Scottsdale, Arizona, United States Recruiting -
Mayo Clinic in Florida
Jacksonville, Florida, United States Recruiting
Study contacts
- Principal investigator: Jewel Samadder, M.D. — Mayo Clinic
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Collecting data on side effects of proton therapy for cancer treatment
This study is trying to learn about the side effects that cancer patients experience after receiving proton therapy to help improve future treatments.
-
In-home cancer treatment with remote specialist support for patients in the Florida Panhandle
This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.
-
Using fucoidan to prevent fatigue in cancer patients undergoing chemotherapy
This study tests if a seaweed supplement called fucoidan can help cancer patients undergoing chemotherapy feel less tired.
-
Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression
This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.
-
Vanguard: a new blood test approach to screen for multiple cancers
This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.
-
Breathing practice to improve brain and mental health in cancer and MS patients
This study tests whether breathing exercises through a mobile app can help improve brain and mental health for people with cancer and multiple sclerosis, along with their caregivers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.